Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701).

Bepler G, Zinner RG, Moon J, Calhoun R, Kernstine K, Williams CC, Mack PC, Oliveira V, Zheng Z, Stella PJ, Redman MW, Gandara DR.

Cancer. 2014 Aug 1;120(15):2343-51. doi: 10.1002/cncr.28714. Epub 2014 Apr 18.

2.

The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival.

Tantraworasin A, Saeteng S, Lertprasertsuke N, Arayawudhikul N, Kasemsarn C, Patumanond J.

Cancer Manag Res. 2013 Oct 3;5:327-36. doi: 10.2147/CMAR.S52073. eCollection 2013.

3.

Biological markers in lung cancer: A clinician's perspective.

Tufman A, Huber RM.

Cancer Biomark. 2010;6(3-4):123-35. doi: 10.3233/CBM-2009-0124. Review.

PMID:
20660959

Supplemental Content

Loading ...
Support Center